Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0RQO.L Stock Summary
Top 10 Correlated ETFs
0RQO.L
In the News
0RQO.L Financial details
Company Rating
Buy
Market Cap
14.39B
Income
245.02M
Revenue
591.08M
Book val./share
8.38
Cash/share
2.57
Dividend
-
Dividend %
-
Employees
110
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
59.87
Forward P/E
53.41
PEG
-1.32
P/S
24.21
P/B
24.16
P/C
87.7
P/FCF
-327.51
Quick Ratio
2.99
Current Ratio
4.03
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
3.76
EPS next Y
4.22
EPS next Q
-
EPS this Y
-455.66%
EPS next Y
12.06%
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
30.62%
Revenue Q/Q
9.19%
EPS Q/Q
-95.45%
-
-
-
-
SMA20
12.62%
SMA50
12.69%
SMA100
52.33%
Inst Own
-
Inst Trans
-
ROA
34%
ROE
63%
ROC
0.02%
Gross Margin
91%
Oper. Margin
2%
Profit Margin
41%
Payout
-
Shs Outstand
65.06M
Shs Float
57.04M
-
-
-
-
Target Price
-
52W Range
74.65-228.4
52W High
-1.15%
52W Low
+204.57%
RSI
58.28
Rel Volume
0.05
Avg Volume
16.82K
Volume
893
Perf Week
3.5%
Perf Month
16.54%
Perf Quarter
86.11%
Perf Half Y
81.38%
-
-
-
-
Beta
1.025
-
-
Volatility
4.05%, 14.93%
Prev Close
-0.25%
Price
225.38
Change
-1.24%
0RQO.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3 | 3.06 | 3.33 | 5.1 | 9.1 | |
Net income per share | -3.1 | -1.72 | -1.34 | -1.06 | 3.77 | |
Operating cash flow per share | -3.16 | -1.7 | -1.3 | -0.73 | -0.28 | |
Free cash flow per share | -3.24 | -1.74 | -1.36 | -0.78 | -0.37 | |
Cash per share | 1.77 | 5.99 | 3.23 | 3.12 | 2.58 | |
Book value per share | 2.4 | 6.75 | 4.15 | 4.17 | 8.39 | |
Tangible book value per share | 2.34 | 6.71 | 4.11 | 4.14 | 8.39 | |
Share holders equity per share | 2.4 | 6.75 | 4.15 | 4.17 | 8.39 | |
Interest debt per share | 0.1 | 0.09 | 0.1 | 0.09 | 0.07 | |
Market cap | 3.92B | 4.46B | 2.82B | 5.18B | 12.24B | |
Enterprise value | 3.84B | 4.12B | 2.63B | 5B | 12.09B | |
P/E ratio | -24.33 | -44 | -32.92 | -76.06 | 49.97 | |
Price to sales ratio | 25.21 | 24.67 | 13.23 | 15.77 | 20.71 | |
POCF ratio | -23.92 | -44.5 | -33.76 | -110.35 | -670.61 | |
PFCF ratio | -23.29 | -43.35 | -32.43 | -103.15 | -503.49 | |
P/B Ratio | 31.53 | 11.19 | 10.6 | 19.28 | 22.46 | |
PTB ratio | 31.53 | 11.19 | 10.6 | 19.28 | 22.46 | |
EV to sales | 24.68 | 22.78 | 12.36 | 15.21 | 20.46 | |
Enterprise value over EBITDA | -25.33 | -45.99 | -34.17 | -86.59 | 408.31 | |
EV to operating cash flow | -23.42 | -41.08 | -31.54 | -106.44 | -662.4 | |
EV to free cash flow | -22.81 | -40.02 | -30.3 | -99.49 | -497.32 | |
Earnings yield | -0.04 | -0.02 | -0.03 | -0.01 | 0.02 | |
Free cash flow yield | -0.04 | -0.02 | -0.03 | -0.01 | 0 | |
Debt to equity | 0.04 | 0.01 | 0.02 | 0.02 | 0.01 | |
Debt to assets | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Net debt to EBITDA | 0.54 | 3.83 | 2.4 | 3.18 | -5.06 | |
Current ratio | 2.62 | 7.31 | 5 | 3.76 | 3.1 | |
Interest coverage | -576.75 | -218.43 | -73.01 | -69.21 | 0 | |
Income quality | 1.02 | 0.99 | 0.98 | 0.69 | -0.07 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.72 | 0 | 0 | |
Sales general and administrative to revenue | 0.28 | 0.25 | 0.21 | 0.22 | 0 | |
Research and developement to revenue | 0.45 | 0.32 | 0.25 | 0.16 | 0.1 | |
Intangibles to total assets | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | 0.03 | 0.03 | 0.04 | 0.07 | 0.33 | |
Capex to revenue | -0.03 | -0.01 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -0.62 | -0.35 | -0.41 | -0.35 | 0 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.03 | 0.05 | 0 | |
Graham number | 12.93 | 16.15 | 11.17 | 9.97 | 26.69 | |
ROIC | -1.2 | -0.24 | -0.31 | -0.25 | 0.61 | |
Return on tangible assets | -0.83 | -0.22 | -0.25 | -0.18 | 0.36 | |
Graham Net | 1.28 | 5.74 | 2.96 | 2.85 | 2.35 | |
Working capital | 107.1M | 381.01M | 246.78M | 248.61M | 272.88M | |
Tangible asset value | 121.26M | 396.17M | 263.31M | 266.85M | 545.18M | |
Net current asset value | 101.1M | 375.06M | 230.26M | 235.92M | 259.3M | |
Invested capital | 0.04 | 0.01 | 0.02 | 0.02 | 0.01 | |
Average receivables | 27.14M | 37.16M | 42.88M | 61.66M | 96.43M | |
Average payables | 13.06M | 13.16M | 15.7M | 21.15M | 21.62M | |
Average inventory | 31.51M | 42.44M | 48.66M | 54.04M | 69.81M | |
Days sales outstanding | 83.56 | 78.15 | 80.64 | 84.69 | 71.98 | |
Days payables outstanding | 262.38 | 240.35 | 229.91 | 222.61 | 143.06 | |
Days of inventory on hand | 756.09 | 863.5 | 635.75 | 531.8 | 606.18 | |
Receivables turnover | 4.37 | 4.67 | 4.53 | 4.31 | 5.07 | |
Payables turnover | 1.39 | 1.52 | 1.59 | 1.64 | 2.55 | |
Inventory turnover | 0.48 | 0.42 | 0.57 | 0.69 | 0.6 | |
ROE | -1.3 | -0.25 | -0.32 | -0.25 | 0.45 | |
Capex per share | -0.09 | -0.04 | -0.05 | -0.05 | -0.09 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.6 | 1.85 | 2.16 | 2.43 | 2.66 | |
Net income per share | -0.32 | 0 | 0.08 | 3.52 | 0.16 | |
Operating cash flow per share | -0.09 | -0.13 | -0.6 | 0.25 | 0.2 | |
Free cash flow per share | -0.11 | -0.14 | -0.61 | 0.24 | 0.14 | |
Cash per share | 3.12 | 2.94 | 2.3 | 2.52 | 2.57 | |
Book value per share | 4.17 | 4.2 | 4.34 | 8.14 | 8.38 | |
Tangible book value per share | 4.14 | 4.07 | 4.21 | 8.01 | 8.38 | |
Share holders equity per share | 4.17 | 4.2 | 4.34 | 8.14 | 8.38 | |
Interest debt per share | 0.08 | 0.09 | 0.09 | 0.1 | 0.07 | |
Market cap | 5.19B | 5.41B | 8.3B | 8.29B | 12.26B | |
Enterprise value | 5.01B | 5.24B | 8.17B | 8.14B | 12.11B | |
P/E ratio | -63.2 | 4.39K | 398.48 | 9.06 | 285.61 | |
Price to sales ratio | 50.29 | 45.18 | 59.13 | 52.43 | 70.99 | |
POCF ratio | -909.46 | -627.14 | -213.89 | 506.76 | 957.15 | |
PFCF ratio | -732.91 | -596.97 | -208.38 | 525.11 | 1.4K | |
P/B Ratio | 19.3 | 19.87 | 29.4 | 15.66 | 22.49 | |
PTB ratio | 19.3 | 19.87 | 29.4 | 15.66 | 22.49 | |
EV to sales | 48.51 | 43.72 | 58.17 | 51.48 | 70.12 | |
Enterprise value over EBITDA | -378.66 | 1.68K | 2.4K | 466.84 | 2.14K | |
EV to operating cash flow | -877.25 | -606.97 | -210.42 | 497.53 | 945.46 | |
EV to free cash flow | -706.96 | -577.76 | -205.01 | 515.55 | 1.38K | |
Earnings yield | 0 | 0 | 0 | 0.03 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Debt to assets | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Net debt to EBITDA | 13.9 | -55.74 | -39.55 | -8.66 | -26.53 | |
Current ratio | 3.76 | 3.69 | 4.1 | 4.03 | 3.1 | |
Interest coverage | 0 | 8.11 | 8.47 | 7.31 | 0 | |
Income quality | 0.28 | -28.01 | -7.45 | 0.07 | 1.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.21 | 0.13 | 0.14 | 0.14 | 0 | |
Research and developement to revenue | 0.14 | 0.1 | 0.1 | 0.08 | 0.1 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.01 | 0 | |
Capex to operating cash flow | 0.24 | 0.05 | 0.03 | -0.03 | -0.31 | |
Capex to revenue | -0.01 | 0 | -0.01 | 0 | -0.02 | |
Capex to depreciation | -0.41 | -0.26 | -0.55 | -0.3 | 0 | |
Stock based compensation to revenue | -0.01 | 0.03 | 0.02 | 0.04 | 0 | |
Graham number | 5.46 | 0.67 | 2.8 | 25.38 | 5.58 | |
ROIC | -0.06 | 0 | 0 | 0.51 | -0.02 | |
Return on tangible assets | -0.06 | 0 | 0.01 | 0.37 | 0.02 | |
Graham Net | 2.85 | 2.68 | 2.65 | 2.77 | 2.35 | |
Working capital | 248.61M | 251.46M | 261.12M | 280.38M | 272.88M | |
Tangible asset value | 266.85M | 263.84M | 273.71M | 520.99M | 545.18M | |
Net current asset value | 235.92M | 240.59M | 251.49M | 271.53M | 259.3M | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Average receivables | 65.1M | 77.79M | 96.48M | 112.84M | 114.29M | |
Average payables | 19.41M | 15.89M | 10.38M | 12.45M | 16M | |
Average inventory | 56.4M | 56.22M | 59.27M | 64.53M | 74.97M | |
Days sales outstanding | 66.52 | 59.59 | 72.87 | 63.72 | 60.73 | |
Days payables outstanding | 240.68 | 64.73 | 92.78 | 89.43 | 125.08 | |
Days of inventory on hand | 574.98 | 442.83 | 461.08 | 482.76 | 530 | |
Receivables turnover | 1.35 | 1.51 | 1.24 | 1.41 | 1.48 | |
Payables turnover | 0.37 | 1.39 | 0.97 | 1.01 | 0.72 | |
Inventory turnover | 0.16 | 0.2 | 0.2 | 0.19 | 0.17 | |
ROE | -0.08 | 0 | 0.02 | 0.43 | 0.02 | |
Capex per share | -0.02 | -0.01 | -0.02 | -0.01 | -0.06 |
0RQO.L Frequently Asked Questions
What is Bonesupport Holding AB (publ) stock symbol ?
Bonesupport Holding AB (publ) is a SE stock and trading under the symbol 0RQO.L
What is Bonesupport Holding AB (publ) stock quote today ?
Bonesupport Holding AB (publ) stock price is $225.38 today.
Is Bonesupport Holding AB (publ) stock public?
Yes, Bonesupport Holding AB (publ) is a publicly traded company.